ARCHIVES

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 19 No. 04 | January 22, 1993

Download PDF Visit The Full Archive

Related Articles

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

HHS Says NIH Improperly Used Program For Scientists To Hire Administrators.

July 13, 2001

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey.

February 16, 2001